Shares in cholesterol drug makers mixed ahead of cardiology conference

March 14, 2015 12:30 AM

6 0

Investing.com -- A trio of pharmaceutical companies embroiled in a race for control of the cholesterol drug market displayed mixed results on Friday ahead of this weekend's American College of Cardiology's annual expo in San Diego.

The three-day conference will feature sessions on nearly a dozen clinical learning pathways, including topics in acute coronary syndromes, congenital heart disease, critical care cardiology, sports cardiology and vascular medicine.

Also read: U.S. Stocks Little Changed as Nasdaq Leads With Earnings Beats

Read more

To category page

Loading...